DR. DOPING

Instructions

Logo DR. DOPING

Instructions / Instruction for use: Histalong

I want this, give me price

Dosage form: Tablets; Tablets for children, dispersible

Active substance: Astemizolum

ATX

R06AX11 Astemizole

Pharmacological group:

H1-Antihistamines

The nosological classification (ICD-10)

H10 Conjunctivitis: Infectious inflammatory conjunctivitis; Bacterial conjunctivitis; Red eye syndrome; Superficial infection of the eye; Chronic non-infectious conjunctivitis

H10.1 Acute atopic conjunctivitis: Allergic conjunctivitis; Allergic eye diseases; Allergic conjunctivitis; Allergic conjunctivitis caused by chemical and physical factors; Allergic rhinoconjunctivitis; Allergic inflammation of the eyes; Spring Qatar; Spring keratitis; Spring conjunctivitis; Conjunctivitis allergic; Year-round allergic conjunctivitis; Exacerbation of pollinosis in the form of rhinoconjunctival syndrome; Acute allergic keratoconjunctivitis; Acute allergic conjunctivitis; Superficial bacterial infection of the eyes; Rhinoconjunctivitis; Seasonal allergic conjunctivitis; Seasonal conjunctivitis; SENSORY; Chronic allergic keratoconjunctivitis; Chronic allergic conjunctivitis

J30 Vasomotor and allergic rhinitis: Allergic rhinopathy; Allergic rhinosinusopathy; Allergic diseases of the upper respiratory tract; Allergic rhinitis; Allergic rhinitis seasonal; Vasomotor runny nose; Prolonged allergic rhinitis; All-year-round allergic rhinitis; All-year allergic rhinitis; Year-round or seasonal allergic rhinitis; All-the-year-round rhinitis of an allergic nature; Rhinitis vasomotor allergic; Exacerbation of pollinosis in the form of rhinoconjunctival syndrome; Acute allergic rhinitis; Edema of the nasal mucosa; Edema of the nasal mucosa; Edema of the mucous membrane of the nasal cavity; Swelling of the nasal mucosa; Swelling of the nasal mucosa; Pollinosis; Permanent allergic rhinitis; Rhinoconjunctivitis; Rhinosinusitis; Rhinosinusopathy; Seasonal allergic rhinitis; Seasonal allergic rhinitis; Hay rhinitis; Chronic allergic rhinitis; Allergic diseases of the respiratory tract

L50 Urticaria: Idiopathic chronic urticarial; Injury Urticaria; Chronic urticarial; Hives of the newborn

T78.3 Angioedema: Edema Quincke; Laryngeal exacerbation with angioneurotic edema; Recurrent angioedema; Allergic edema; Recurrent swelling of Quincy

T78.4 Unspecified Allergy: Allergic reactions to insulin; Allergic reactions to insect stings; Allergic reactions similar to systemic lupus erythematosus; Allergic diseases; Allergic diseases of mucous membranes; Allergic diseases and conditions resulting from increased release of histamine; Allergic diseases of mucous membranes; Allergic symptoms; Allergic symptoms in the mucous membranes; Allergic reactions; Allergic reactions caused by insect bites; Allergic reactions; Allergic conditions; Allergic laryngeal edema; allergopathy; allergic conditions; Allergy; House dust allergy; Anaphylaxis; Cutaneous reactions to medications; Skin reaction to insect stings; Cosmetic allergy; Drug allergy; Acute allergic reaction; Laryngeal edema allergic genesis and background radiation; Food and drug allergy

Composition and release form

1 tablet contains astemizole 10 mg; In a contour acheikova packing 10 pcs., In a cardboard pack 2 packages.

1 tablet is dispersible, flavored for children - 5 mg; In contour acheikova packing 10 pcs. (Complete with a measuring spoon), in a cardboard bundle 2 packages.

Pharmachologic effect

Pharmacological action - antiallergic.

It blocks histamine H1 receptors and reduces the body's response to histamine.

Pharmacodynamics

Reduces the permeability of capillaries and caused by histamine swelling of the tissues, prevents the development and facilitates the course of allergic reactions. Does not have a pronounced sedative effect.

Indications of the drug Histalong

Allergic rhinitis, conjunctivitis, urticaria, Quincke's edema and other allergic diseases.

Contraindications

Hypersensitivity, pregnancy, breast-feeding, age to 2 years.

Application in pregnancy and breastfeeding

Contraindicated in pregnancy. For the duration of treatment, breastfeeding should be stopped.

Side effects

From the nervous system and sensory organs: disturbed sleep and mood, nightmares, paresthesia.

From the cardiovascular system and blood (hematopoiesis, hemostasis): prolongation of the QT interval, arrhythmia, cardiac arrest.

From the musculoskeletal system: arthralgia, myalgia.

Allergic reactions: skin rash, itching, bronchospasm, angioedema, anaphylactic reactions.

Other: increased appetite, transient increase in hepatic transaminase activity, weight gain.

Dosing and Administration

Inside, on an empty stomach, 1 hour before or 2 hours after a meal. Adults and children from 12 years - 10 mg / day. Children from 6 to 12 years - 5 mg 1 time per day; Children from 2 to 6 years - 2 mg / 10 kg 1 time per day.

Precautionary measures

It should be used with caution when the QT interval is prolonged (on the ECG), hypokalemia, marked violations of the liver function.

Storage conditions of the drug Histalong

In a dry, the dark place at a temperature of no higher than 25 ° C.

Keep out of the reach of children.

Shelf life of the drug Histalong

3 years.

Do not use after the expiry date printed on the package.